NervGen Pharmaceuticals(니브젠) 상장 공모 소식과 기존 주주들에게 주는 고민 🤔

Biotech offerings are very (very, very) common. As someone who enjoys investing in biotech with a reasonable allocation, if something good happens and the stock goes up, I am never surprised to see an offering shortly after.

That said, I tend to focus more on sort of "high end of small + mid caps" and if something does an offering, my expectations are for the offering to occur at a price within the same neighborhood as the stock was at. $2.20 offering when the stock closed at $3.60 isn't great.

Not familiar with the company.

So yes, offerings are veeerrry common in biotech, but I tend to like to see the offering take place at a price at least close (if the stock is $100, maybe the offering is in the $85-95 range kind-of-thing), not almost 40% lower. But again, not familiar with the company and I tend to focus on somewhat larger companies.